Structure and Orientation of Peptide Inhibitors Bound to Beta-amyloid Fibrils
Authors:
- Gerd KrauseGKGerd Krause
- Bernd ReifBRBernd Reif
- 1 December 2005
- journal article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 354 (4) , 760-776
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Harnessing Chaperones to Generate Small-Molecule Inhibitors of Amyloid ß AggregationScience, 2004
- Therapeutic approaches to protein-misfolding diseasesNature, 2003
- Beta‐sheet breaker strategy for the treatment of Alzheimer's diseaseDrug Development Research, 2002
- The amyloid‐β peptide and its role in Alzheimer's diseaseJournal of Peptide Science, 2001
- Approaches to discovery and characterization of inhibitors of amyloid β-peptide polymerizationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2000
- The Alzheimer family of diseases: Many etiologies, one pathogenesis?Proceedings of the National Academy of Sciences, 1997
- Arrest of -Amyloid Fibril Formation by a Pentapeptide LigandJournal of Biological Chemistry, 1996
- Fibrillogenesis of synthetic amyloid-β peptides is dependent on their initial secondary structureNeuroscience Letters, 1995
- Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease βA4 peptidesJournal of Molecular Biology, 1992
- The molecular pathology of Alzheimer's diseaseNeuron, 1991